Status:
COMPLETED
Test of the Nipro ELISIO H Dialyzer in Different Dialysis Treatment Procedures
Lead Sponsor:
EXcorLab GmbH
Collaborating Sponsors:
Nipro Europe N.V.
Conditions:
Chronic Kidney Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A current trend in dialysis membrane engineering is to maximize the permeability for larger low-molecular weight proteins while retaining albumin. Protein-leaking dialysis membranes do not meet these ...
Eligibility Criteria
Inclusion
- Age ≥18 years
- CKD stage 5 with hemodialysis or hemodiafiltration treatment for more than three months
- Hematocrit \>30 %
- Routine anticoagulation and erythropoietin regimen
- No vascular access related problems (A/V-fistula, graft or bi-flow catheter)
- No ongoing infection
- Signed informed consent form
Exclusion
- Inclusion criteria not met
- Known HIV or active hepatitis B or C infection (positive PCR). Pregnancy
- Unstable clinical condition (e.g. cardiac or vascular instability)
- Life expectancy less than 12 months
- Known coagulation problems
- Patients participating in another study interfering with the planned study
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2009
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT00735059
Start Date
August 1 2008
End Date
April 1 2009
Last Update
August 21 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Ghent, Belgium, B-9000